At Lonza we always welcome interest and inquiries from the media about our business, services and capabilities. Please use the resources on this page, or contact our media relations team for specific inquiries, and we will connect you to the appropriate business leader or subject matter expert.

08 September 2020
Sheba Medical Center Treats First Patient with CAR-T Cell Immunotherapy...
First cancer patient dosed at Sheba Medical Center, Isreal with autologous CAR-T therapy manufactured using Lonza’s Cocoon® PlatformIsraeli...
13 July 2020
Junshi Biosciences and Lonza Partner to Produce a Neutralizing Antibody Tackling...
Junshi Biosciences developing therapies for COVID-19 in collaboration with a number of global partnersJunshi Biosciences' first SARS-CoV-2...
24 July 2020
Lonza’s Pharma Biotech Business Drives Strong H1 2020 Group Sales Growth and...
Strong operational performance maintained during COVID-19; sites remained open and protection of employees continues to be a top priorityLandmark...